TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
23 hedge funds and large institutions have $2.45M invested in TFF Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 19 closing their positions.
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
39% less capital invested
Capital invested by funds: $4.04M → $2.45M (-$1.59M)
43% less funds holding
Funds holding: 40 → 23 (-17)
89% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$49.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$43.3K |
| 3 |
Renaissance Technologies
New York
|
+$41K |
| 4 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$8.56K |
| 5 |
JP Morgan Chase
New York
|
+$8.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$596K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$226K |
| 3 |
GS
Gagnon Securities
New York
|
-$56.9K |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$50.8K |
| 5 |
Millennium Management
New York
|
-$25K |
TFFP Hedge Fund Activity: Q4 2023 in Review
23 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q4 2023, worth a combined $2.45M — down 39% from $4.04M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of TFFP and 2 opened new positions — a net loss of 17 holders — while 10 trimmed existing stakes and 7 added.
The largest buyer was Westside Investment Management, adding an estimated $49.7K. The largest seller was AIGH Capital Management, cutting an estimated $596K.
- 23 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q4 2023, down from 40 in Q3 2023.
- Funds reported $2.45M of TFF Pharmaceuticals, Inc. Common Stock stock for Q4 2023, down 39% quarter-over-quarter.
- 2 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q4 2023 and 19 closed out, a net change of -17 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q4 2023 was Westside Investment Management, an estimated $49.7K added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q4 2023 was AIGH Capital Management, an estimated $596K sold.
Based on aggregated 13F filings for Q4 2023.